End-of-day quote
Shanghai S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
2.49
CNY
|
-3.86%
|
|
+3.75%
|
-32.52%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,062
|
3,386
|
4,671
|
5,609
|
4,304
|
4,096
|
Enterprise Value (EV)
1 |
2,896
|
3,487
|
5,362
|
5,871
|
4,052
|
4,543
|
P/E ratio
|
41.8
x
|
-42.6
x
|
24.5
x
|
29.6
x
|
-121
x
|
-8.39
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
21.1
x
|
32.6
x
|
1.71
x
|
1.32
x
|
0.71
x
|
1.27
x
|
EV / Revenue
|
19.9
x
|
33.5
x
|
1.96
x
|
1.38
x
|
0.67
x
|
1.41
x
|
EV / EBITDA
|
-104
x
|
-42.8
x
|
9.13
x
|
12.5
x
|
15.4
x
|
-11.6
x
|
EV / FCF
|
-146
x
|
-13.2
x
|
99.7
x
|
20.2
x
|
7.25
x
|
-12.6
x
|
FCF Yield
|
-0.69%
|
-7.56%
|
1%
|
4.94%
|
13.8%
|
-7.92%
|
Price to Book
|
20
x
|
38.5
x
|
1.99
x
|
1.9
x
|
1.48
x
|
1.71
x
|
Nbr of stocks (in thousands)
|
611,271
|
611,271
|
1,002,406
|
1,185,788
|
1,185,788
|
1,110,045
|
Reference price
2 |
5.010
|
5.540
|
4.660
|
4.730
|
3.630
|
3.690
|
Announcement Date
|
3/11/19
|
4/23/20
|
3/17/21
|
4/8/22
|
3/14/23
|
4/23/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
145.3
|
104
|
2,735
|
4,247
|
6,048
|
3,225
|
EBITDA
1 |
-27.93
|
-81.48
|
587.3
|
471.2
|
263.1
|
-391.3
|
EBIT
1 |
-33.14
|
-85.81
|
368.4
|
245.4
|
35.44
|
-621.2
|
Operating Margin
|
-22.81%
|
-82.5%
|
13.47%
|
5.78%
|
0.59%
|
-19.26%
|
Earnings before Tax (EBT)
1 |
71.77
|
-80.03
|
256.3
|
232.5
|
-44.53
|
-623.3
|
Net income
1 |
72.48
|
-79.85
|
186
|
187.8
|
-38.24
|
-521
|
Net margin
|
49.89%
|
-76.78%
|
6.8%
|
4.42%
|
-0.63%
|
-16.15%
|
EPS
2 |
0.1200
|
-0.1300
|
0.1900
|
0.1600
|
-0.0300
|
-0.4400
|
Free Cash Flow
1 |
-19.85
|
-263.5
|
53.81
|
290.1
|
558.8
|
-359.9
|
FCF margin
|
-13.66%
|
-253.34%
|
1.97%
|
6.83%
|
9.24%
|
-11.16%
|
FCF Conversion (EBITDA)
|
-
|
-
|
9.16%
|
61.55%
|
212.4%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
28.93%
|
154.45%
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/11/19
|
4/23/20
|
3/17/21
|
4/8/22
|
3/14/23
|
4/23/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
100
|
691
|
263
|
-
|
447
|
Net Cash position
1 |
166
|
-
|
-
|
-
|
253
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-1.23
x
|
1.176
x
|
0.5574
x
|
-
|
-1.143
x
|
Free Cash Flow
1 |
-19.8
|
-263
|
53.8
|
290
|
559
|
-360
|
ROE (net income / shareholders' equity)
|
103%
|
-81.3%
|
7.35%
|
6.57%
|
-1.31%
|
-19.7%
|
ROA (Net income/ Total Assets)
|
-3.7%
|
-9.63%
|
5.25%
|
3.2%
|
0.46%
|
-8.53%
|
Assets
1 |
-1,959
|
829.1
|
3,544
|
5,871
|
-8,367
|
6,108
|
Book Value Per Share
2 |
0.2500
|
0.1400
|
2.340
|
2.480
|
2.450
|
2.150
|
Cash Flow per Share
2 |
0.3000
|
0.1600
|
0.7300
|
0.7100
|
1.200
|
0.6400
|
Capex
1 |
2.47
|
1.27
|
42.3
|
59.9
|
83.2
|
256
|
Capex / Sales
|
1.7%
|
1.22%
|
1.55%
|
1.41%
|
1.37%
|
7.93%
|
Announcement Date
|
3/11/19
|
4/23/20
|
3/17/21
|
4/8/22
|
3/14/23
|
4/23/24
|
|
1st Jan change
|
Capi.
|
---|
| -32.52% | 382M | | +2.80% | 103B | | +1.20% | 67.05B | | +44.29% | 40.4B | | +15.99% | 38.64B | | +3.89% | 32.41B | | +6.82% | 19.17B | | +12.32% | 16.76B | | +17.69% | 15.07B | | +8.31% | 14.82B |
Other Commodity Chemicals
|